PropertyValue
?:abstract
  • A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.
is ?:annotates of
?:creator
?:journal
  • Trends_Neurosci
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • PET Imaging as a Tool for Assessing COVID-19 Brain Changes
?:type
?:who_covidence_id
  • #885448
?:year
  • 2020

Metadata

Anon_0  
expand all